Frequently Asked Questions Does Retatrutide cause hair loss
More than a decade later, Novo Nordisk pioneered the creation of a new GLP-1 RA, semaglutide
A Research Guide Retatrutide is the triple incretin agonist defining the next generation of metabolic peptide research
-Lisa DeBolt- I kept seeing the amazing price for the T compound and decided to take the leap of faith and hope this was a legit deal
Instead of targeting a single receptor, retatrutide activates three hormone receptors involved in appetite and metabolism: GLP-1 receptor GIP receptor Glucagon receptor Because it activates all three pathways, it is often called a triple agonist
An observational study published in 2023 in Diabetes Care that looked to determine whether the use of GLP-1 medications was associated with an increased risk of thyroid cancer found that in 1-3 years of treatment, the risk for thyroid cancer was increased for those taking GLP-1 medications (2)